The purpose of this study was to investigate the predictors of metastatic patterns of upper tract urothelial carcinoma (UTUC) and to analyze the surgical outcomes of different metastatic patterns of UTUC. Data on patients with UTUC from 2010 to 2017 were retrieved from the Surveillance, Epidemiology, and End Results Program (SEER) database. Kaplan–Meier analysis was applied to compare the patients' survival distributions. Univariate and multivariate logistic regression was used to assess the specific predictors of site-specific metastases, while competitive risk regression was applied to estimate the predictors of cancer-specific mortality in patients with metastases. A total of 9,436 patients were enrolled from the SEER database, of which 1,255 patients had distant metastases. Lung metastasis (42.5%) was most common and patients with single distant lymph node metastasis had a better prognosis. Clinical N stage (N1, N2, N3) was the strongest predictors of the site specific metastatic sites. Renal pelvis carcinoma was more prone to develop lung metastases (OR = 1.67, P < 0.01). Resection of the primary tumor site is beneficial for the prognosis of patients with metastatic UTUC, whether local tumor resection (HR = 0.72, P < 0.01) or nephroureterectomy (HR = 0.64, P < 0.01). Patients with single distant lymph node metastasis have the greatest benefit in nephroureterectomy compared to other specific-site metastases (median survival 19 months vs. 8 months). An understanding of distant metastatic patterns and surgical outcomes in patients with UTUC is important in clinical settings and helpful in the design of personalized treatment protocols.
Few studies have focused on the link between active surveillance (AS) and Gleason score upgrade (GSU) and its impact on the prognosis of patients with prostate cancer (PCa). This study aimed to analyze the effect of AS duration on GSU and prognostic value based on risk stratification. All eligible patients were risk-stratified according to AUA guidelines into low-risk (LR), favorable intermediate-risk (FIR), and unfavorable intermediate-risk (UIR) PCa. Within the Surveillance, Epidemiology, and End Results Program (SEER) database, 28,368 LR, 27,243 FIR, and 12,210 UIR PCa patients were included. The relationship between AS duration and GSU was identified with univariate and multivariate logistic regression. Discrimination according to risk stratification of AS duration and GSU was tested by Kaplan–Meier analysis and competing risk regression models. The proportion of patients who chose AS was the highest among LR PCa (3434, 12.1%), while the proportion in UIR PCa was the lowest (887, 7.3%). The AS duration was only associated with GSU in LR PCa, with a high Gleason score (GS) at diagnosis being a strong predictor of GSU for FIR and UIR PCa. Kaplan–Meier analysis indicated that long-term surveillance only made a significant difference in prognosis in UIR PCa. The competing risk analysis indicated that once GS was upgraded to 8 or above, the prognosis in each group was significantly worse. AS is recommended for LR and FIR PCa until GS is upgraded to 8, but AS may not be suitable for some UIR PCa patients.
Introduction: The present existing data on the association of metastatic sites and prognosis of patients with metastatic adrenal malignancy are limited. This study aims to investigate the impact of different distant metastases pattern on the survival of patients with adrenal malignancy. Methods: A dataset from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) 18 Registries (2000–2017) was selected for a retrospective metastatic adrenal malignancy cohort study. There was information on distribution of metastatic lesions in bone, brain, liver, and lung in the SEER database. Kaplan-Meier analysis and nomogram analyses were applied to compare the survival distribution of cases. Univariate and multivariate cox regression models were used to analyze survival outcomes. Results: From the SEER database, a total of 980 patients with primary metastatic adrenal malignancy from 2010 to 2017 were enrolled in this cohort study. Based on the initial metastatic sites, 42.3%, 38.4%, 30.5%, and 4.9% of patients were found bone, liver, lung, and brain metastasis, respectively. Patients who had a single site of distant metastases accounted for 52.6% (515/980) and had a better overall survival (OS) and cancer-specific survival (CSS) (both P < 0.001). In contrast with the tumor arising from the cortex, the tumor from the medulla showed better survival outcomes in both OS and CSS (P < 0.001). Conclusion: Different histological types possess various metastatic features and prognostic values. Understanding these differences may contribute to designing targeted pre-treatment assessment of primary metastatic adrenal malignancy and creating a personalized curative intervention.
This retrospective study compares the efficacy and safety of transurethral resection of the prostate (TURP), green-light photoselective vaporization of the prostate (PVP), and holmium laser enucleation of the prostate (HoLEP) in treating small-volume benign prostatic hyperplasia (BPH). Data from 645 patients with small-volume BPH (2012–2022, Zhejiang Provincial People’s Hospital) were analyzed. Baseline characteristics, surgical details, complications, and follow-up outcomes were compared. Logistic regression identified risk factors for urinary incontinence (UI) and bladder neck contracture (BNC). TURP was associated with a longer operative duration (53.15 ± 21.96 min) and catheterization time (5.29 ± 1.31 days) compared to PVP (48.53 ± 22.38 min, 4.84 ± 1.05 days) and HoLEP (45.00 ± 19.04 min, 4.79 ± 0.96 days). The incidence of BNC was significantly higher in the TURP group (9.4%) than in the PVP (4.8%) and HoLEP (5.7%) groups. Within 1 month postoperatively, the TURP group had a significantly higher proportion of patients with urinary incontinence. Between 1 and 3 months post-surgery, only UI with need for drug use (UIWD) remained significantly higher in the TURP group (8.2%). Preoperative indwelling catheterization, detrusor underactivity, severely elevated detrusor pressure, and undergoing TURP were identified as independent risk factors for UI. Green-light PVP was found to be a protective factor against BNC (OR = 0.40, P = 0.043). Green-light PVP and HoLEP showed similar efficacy and safety, with PVP offering the shortest operative time. TURP was associated with higher rates of BNC and UI. Laser techniques are preferable for high-risk patients.
This study evaluated the safety and efficacy of self-retaining barbed double-layer sutures (SRBDS) used for wound sutures in stage T1 renal cancer undergoing peritoneal robot-assisted laparoscopic partial renal resection. A total of 50 patients undergoing robot-assisted laparoscopic partial nephrectomy (RAPN) for localized renal tumors (< 7 cm) in Zhejiang Provincial People’s Hospital from January 2021 to January 2022 were selected. The experimental-group and the control-group randomly included 25 patients, respectively. SRBDS was intended to be used for kidney wound repair in the experimental group, and single-needle Vicryl was applied in the control group. Patients in both the experimental group and the control group completed RAPN without conversion to open surgery. The operative time (80.20 ± 18.39 min) and warm ischemia time (11.76 ± 1.16 min) of the experimental group were both reduced compared to the control group (86.00 ± 15.94 min, 14.56 ± 1.04 min). The increased changes in blood creativity at one week and three months postoperatively in the experimental group were significantly lower than those in the control group, and the decreased changes in GFR level at three months postoperatively in the experimental group were significantly lower than that in the control group (5.21 ± 2.14 vs 7.81 ± 2.28, P < 0.05). For localized T1 renal carcinoma, SRBDS is a safe and efficient endoscopic suture technique, which may be considered as an alternative to other suturing techniques, tissue sealants, and glues for RAPN in the future.
Pheochromocytomas are rare neuroendocrine tumors that can cause life-threatening cardiovascular complications due to excessive catecholamine secretion. One such severe manifestation is Takotsubo syndrome (TS), a catecholamine-induced cardiomyopathy that exacerbates hemodynamic instability. The coexistence of a giant pheochromocytoma and TS is extremely rare and presents formidable diagnostic and therapeutic challenges. This case highlights the successful emergency management of this complex condition, demonstrating the feasibility of robotic adrenalectomy in hemodynamically unstable patients. A 45-year-old male presented with dizziness, headache, chest tightness, and palpitations. He was found to have severe hypertension (220/130 mmHg), elevated cardiac biomarkers (BNP 114 pg/mL, cTnI 0.046 ng/mL), and a large left adrenal mass (119 mm × 139 mm × 130 mm). During hospitalization, he experienced alternating hypertensive crises (peak 261/151 mmHg) and profound hypotension (54/32 mmHg), with echocardiography revealing apical ballooning and reduced ejection fraction (45%), consistent with TS. Biochemical analysis showed markedly elevated plasma catecholamine. Given the severe hemodynamic instability despite intensive medical management, an emergency robot-assisted left adrenalectomy was operated. Intraoperatively, significant blood pressure fluctuations occurred (peak 230/100 mmHg), requiring additional vasoactive agent. Pathologic examination confirmed a 14 cm pheochromocytoma. Postoperatively, cardiac function normalized within three months, and catecholamine levels returned to baseline. This case highlights the critical association between pheochromocytoma and TS, underscoring the potential for severe hemodynamic instability in such patients. The successful use of urgent robotic adrenalectomy demonstrates its feasibility and advantages in managing giant pheochromocytoma, even in high-risk patients. This report contributes to the growing evidence supporting minimally invasive techniques in endocrine surgery and emphasizes the necessity of multidisciplinary collaboration in optimizing outcomes for complex pheochromocytoma cases.